Item View & Download Statistics: Transform-1: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, International Phase 3 Study of Navitoclax in Combination with Ruxolitinib Versus Ruxolitinib Plus Placebo in Patients with Untreated Myelofibrosis

From:   ever     To:   now     Change date range
Email Alert
RSS Feed
 
Geo Map
Save as a PNG Save as a JPEG
Region #
NA - North America 35
AS - Asia, other 13
EU - Europe 2
Unknown 2
Total 52
Save as a PNG Save as a JPEG
Country #
US - United States of America 35
SG - Singapore 11
RU - Russian Federation 2
CN - China 1
HK - Hong Kong 1
Unknown 2
Total 52
Save as a PNG Save as a JPEG
City #
Ashburn 2
Singapore 2
Council Bluffs 1
Hong Kong 1
Moscow 1
Wuxi 1
Unknown 44
Total 52
Save as a PNG Save as a JPEG


Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Tot
2024 00 001210 5634 21 43
2025 45 0000 0000 00 9
Ever 52